20 completed, 6 unknown, 5 recruiting, 3 active not recruiting. 18 Not applicable, 4 Phase 2, 3 Phase 4, 2 Phase 3, 1 Early Phase 1.
Follow Sodium: new trials by email Literature Review of Sodium trials Research Report on Sodium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Belatacept in Heart Transplantation Belatacept, Tacrolimus, Mycophenolate Mofetil/Sodium - Heart Transplant | Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 66 | 2025-01-29 | 2026-10-09 |
| To Evaluate the Safety and PK Characteristics After Co-administration of JW0104 and C2402 and Administration of JW0105 Treatment A_Period 1, Treatment B_Period 2, Treatment A_Period 3 - Healthy | Phase 1 | Completed | JW Pharmaceutical | 60 | 2025-01-17 | 2025-09-09 |
| Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia JW0104+C2402, JW0104+C2403, C2402 - Hypertension, Dyslipidemia | Phase 3 | Recruiting | JW Pharmaceutical | 162 | 2024-12-02 | 2025-09-09 |
| Development of Microfluidic Patch-type Sweat Sensor Time-course changes in Sodium and Creatinine levels. - Diseases of the Genitourinary System | Not applicable | Completed | Korea University | 5 | 2024-06-15 | 2026-01-15 |
| Genomic Profiling of Pancreatic Cystic Tumors NA (No intervention) - Pancreatic Cyst | Not yet recruiting | Samsung Medical Center | 250 | 2024-01-15 | 2024-01-08 | |
| Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use in France Sodium/glucose cotransporter-2 inhibitors (SGLT2i) - Diabetes Mellitus, Type 2 | Active not recruiting | Boehringer Ingelheim | 547150 | 2023-11-15 | 2026-10-13 | |
| Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA. Peg-IFNα-2b combined with NA, Nucleotide Analogues - HBV | Recruiting | Xiangya Hospital of Central South University | 400 | 2023-05-25 | 2024-12-24 | |
| Salt and HMB Study Sodium, HMB, Placebo - Blood Pressure | Not applicable | Unknown | Augusta University | 80 | 2021-10-01 | 2022-08-25 |
| The Effect of Low Sodium Diet on Idiopathic Hyperaldosteronism Sodium - Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral) | Not applicable | Completed | Shanghai Jiao Tong University School of Medicine | 50 | 2021-07-01 | 2022-12-14 |
| Genetic Epidemiology of Rotator Cuff Tears: The cuffGEN Study NA (not an interventional study) - Rotator Cuff Tears | Recruiting | University of Michigan | 3500 | 2021-03-04 | 2026-02-10 | |
| Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis Blood sampling, cerebrospinal fluid , post-mortem cerebral tissues (NA for the Group 3), Blood sampling, cerebrospinal fluid, stool sampling post-mortem cerebral tissues (NA for the Group 3) - Status Epilepticus, Dysimmune Encephalopathy | Not applicable | Recruiting | Assistance Publique - Hôpitaux de Paris | 400 | 2020-11-25 | 2026-05-22 |
| Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors NA (Observational) - Prostate Cancer | Active not recruiting | University College, London | 60 | 2020-07-01 | 2024-02-26 | |
| Understanding COVID-19 NA (no intervention) - SARS-CoV-2 Viral Kinetics and Host Immune Responses | Completed | University Hospital, Geneva | 86 | 2020-03-27 | 2022-05-24 | |
| Cardiac Amyloidosis in HFpEF NA, observational study - Heart Failure With Preserved Ejection Fraction, Amyloidosis Cardiac | Unknown | National Taiwan University Hospital | 250 | 2019-08-01 | 2024-07-05 | |
| A Post-marketing Surveillance to Assess Safety and Efficacy of Rosuvatatin/Ezetimibe NA (Observation study) - Mixed Dyslipidemia | Unknown | IlDong Pharmaceutical Co Ltd | 600 | 2018-09-01 | 2018-09-06 | |
| Modulation of Tissue Sodium in Hemodialysis Patients Change of dialysate [Na+] - Chronic Kidney Disease Requiring Chronic Dialysis | Not applicable | Completed | University of Erlangen-Nürnberg Medical School | 10 | 2018-05-15 | 2023-10-26 |
| Effects of Acute Dietary Sodium on Cerebrovascular Reactivity and Blood Pressure Reactivity Low Sodium Meal (138 mg sodium), High Sodium Meal (1,495 mg sodium) - Blood Pressure, Cerebrovascular Reactivity | Not applicable | Completed | University of Delaware | 37 | 2018-05-01 | 2020-09-22 |
| An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection JNJ-56136379, Placebo, NA (ETV or TDF) - Hepatitis B | Phase 2 | Completed | Janssen Sciences Ireland UC | 232 | 2018-02-13 | 2022-11-17 |
| Rehabilitation Treatment of Time Deficits in Brain-damaged Patients Prismatic googles inducing prismatic adaptation (PA) associated to Virtual Reality (VR), Neutral googles inducing no-adaptation (NA) associated to Virtual Reality (VR) - Brain Damage | Not applicable | Completed | Istituti Clinici Scientifici Maugeri SpA | 20 | 2018-02-01 | 2023-09-29 |
| Point Of Care With Serial NT-proBNP Measurement in Patients With Acute Decompensation of Heart Failure Serial measurements of NT-pro BNP, potassium, sodium, and creatinine every second business day - Acute Decompensated Heart Failure | Not applicable | Completed | Prof. Dr. Jörg Leuppi | 52 | 2018-01-23 | 2020-07-17 |
Showing 20 of 38. Sign in to see all of them.
Hypertension (4) · Prostatic Neoplasms (2) · Thyroid Diseases (2) · Thyroid Neoplasms (2) · Amyloid Neuropathies, Familial (1) · Autoimmune Diseases (1) · Brain Injuries (1) · Chediak-Higashi Syndrome (1) · Common Variable Immunodeficiency (1) · Dental Caries (1) · Diabetes Mellitus, Type 2 (1) · Dyslipidemias (1) · Epilepsy (1) · Granulomatous Disease, Chronic (1) · Hepatitis B (1)
JW Pharmaceutical (2) · Medstar Health Research Institute (2) · Allergopharma GmbH & Co. KG (1) · Assistance Publique - Hôpitaux de Paris (1) · Augusta University (1) · Boehringer Ingelheim (1) · Cytonet GmbH & Co. KG (1) · Fox Chase Cancer Center (1) · Fujian Medical University (1) · Government Dental College and Research Institute, Bangalore (1) · IlDong Pharmaceutical Co Ltd (1) · Istituti Clinici Scientifici Maugeri SpA (1) · Janssen Sciences Ireland UC (1) · Korea University (1) · Masonic Cancer Center, University of Minnesota (1)
United States (11) · South Korea (6) · China (4) · Germany (4) · France (3) · Italy (3) · Belgium (2) · Canada (2) · Denmark (2) · Switzerland (2) · Taiwan (2) · United Kingdom (2) · Brazil (1) · Hong Kong (1) · India (1)
Douglas Van Nostrand, MD (2) · Boye L. Jensen, Professor (1) · Christian P. Larsen, MD, DPhil (1) · Christoph Kopp, MD (1) · Claire-Anne Siegrist, MD (1) · Doris Neuenhofer, MD (1) · Elizabeth Plimack, MD (1) · Francesca Frassinetti, PhD (1) · Hyun-Kyung Do (1) · Jae-Young Lim (1) · Johanna M Geleijnse, PhD (1) · Jon A. Kobashigawa, MD (1) · Joren C Madsen, MD, DPhil (1)
PMID 22326832, PMID 24821881, PMID 28806263, PMID 28894899, PMID 29602821, PMID 31238011, PMID 32094138, PMID 32506135, PMID 33568190, PMID 36697207, PMID 37152926, PMID 37385475, PMID 39418289
2017 (2), 2014 (1), R01AR074989 (1)